[Construction and identification of small interfering RNA expression plasmid targeting Sox9 and the function to cell

Hong-Min Qin1, Hui-Feng Han, Tie Xu

  • 1Xuzhou Medical College Hospital, Xuzhou 221002, China. qinhongmin07@yahoo.com.cn

Abstract

Insights

Small interfering RNA (siRNA) targeting Sox9 was successfully delivered into human chondrosarcoma cells, significantly reducing Sox9 expression and inhibiting tumor cell growth while promoting apoptosis.

Area of Science:

  • Molecular Biology
  • Cancer Research

Context:

  • Chondrosarcoma is a rare bone cancer.
  • Sox9 is a transcription factor implicated in chondrosarcoma development.

Purpose:

  • To construct and deliver a small interfering RNA (siRNA) Sox9 expression plasmid into human chondrosarcoma cells (HTB-94).
  • To evaluate the impact of Sox9 knockdown on cell growth and apoptosis in HTB-94 cells.

Summary:

  • A synthesized siRNA Sox9 expression plasmid was successfully transfected into HTB-94 cells.
  • Enzyme digestion and DNA sequencing confirmed the recombinant plasmid.
  • Transfection significantly reduced both mRNA and protein expression of Sox9.
  • HTB-94 cell proliferation was inhibited, and apoptosis was markedly increased.

Impact:

  • This study demonstrates the efficacy of siRNA-mediated Sox9 knockdown in inhibiting chondrosarcoma cell growth.
  • The findings suggest a potential therapeutic strategy targeting Sox9 in chondrosarcoma treatment.

Related Concept Videos